文献速递其他结缔组织病

外科手术在系统性硬化症食管受累中的作用:一项系统文献综述

The role of surgery in esophageal involvement in systemic sclerosis: A systematic literature review.
PubMed 文献 · Semin Arthritis Rheum · 2025-07-25

该系统文献综述基于PICO框架检索多个数据库至2024年9月1日,纳入23项研究、184例接受抗反流手术的系统性硬化症患者。多数研究来自外科环境且缺乏风湿病学数据,胃底折叠术在14项研究中有效减轻胃食管反流症状、4项报告不利结果,所有研究均报告手术相关死亡率和发病率低。作者认为难治性胃食管反流的手术管理因证据有限且质量差仍具挑战,但胃底折叠术的安全性和获益提示其可能对部分患者有益。

要点

  • 23项研究、184例系统性硬化症患者接受抗反流手术,多数研究来自外科环境且风湿病学数据 largely 缺失。
  • 难治性胃食管反流症状是最常见手术指征,术后吞咽困难是最常见并发症。
  • 14项研究显示胃底折叠术有效减轻胃食管反流症状,1项结果不确定,4项报告不利结果。

核心结论

  • 难治性胃食管反流的手术管理因证据有限且质量 largely 差仍具挑战。
  • 胃底折叠术在多数系统性硬化症患者中获得的安全性和有益效果提示其可能对部分患者是有益干预。
  • 作者认为需要定义开展难治性胃食管反流手术研究的最低要求、识别最可能从胃底折叠术获益的特定系统性硬化症亚群并确定最佳手术时机。

研究设计与样本

  • 系统文献综述基于PICO框架制定4个研究问题,检索完成于2024年9月1日。
  • 检索数据库包括PubMed、MEDLINE(OVID)、EMBASE、Cochrane Library、Web of Science、Google Scholar、Emcare和Academic Search Premier。
  • 两名评价者独立筛选文献、独立评估合格全文并提取数据;因纳入研究异质性大,采用叙述性总结呈现数据。
  • 共检索到986篇论文,23项研究符合纳入标准,其中184例系统性硬化症患者接受抗反流手术并纳入分析。

主要发现

  • 多数研究在外科环境中进行,相关风湿病学数据 largely 缺失。
  • 难治性胃食管反流症状是最常见的手术指征,术后吞咽困难是最常见的并发症。
  • 14项研究中胃底折叠术有效减轻胃食管反流症状,1项研究结果不确定,4项研究报告胃底折叠术不利结果。
  • 所有纳入研究均报告与手术相关的低死亡率和低发病率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据有限且质量 largely 差。
  • 多数研究在外科环境中进行,相关风湿病学数据 largely 缺失。
  • 作者认为需要定义开展难治性胃食管反流手术研究的最低要求、识别最可能从胃底折叠术获益的特定系统性硬化症亚群并确定最佳手术时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastroesophageal reflux disease (GERD) is one of the earliest clinical manifestations of systemic sclerosis (SSc). Proton pump inhibitors are ineffective in controlling symptoms in up to 40 % of cases, and their chronic use (often) at high-doses and long-term safety are a concern. For this reason, surgery has been proposed as an alternative management strategy for refractory GERD in SSc patients. However, consensus on the optimal surgical procedure, timing, and ideal patient population, is still lacking. OBJECTIVES: To evaluate and compare the safety, efficacy, indications, timing and feasibility of different surgical approaches to fundoplication (FP) for treating SSc-related refractory GERD. METHODS: Four research questions based on the PICO framework were developed to guide the systematic literature review (SLR) which was completed 01 September 2024. The search was performed across different databases including PubMed, MEDLINE (OVID), EMBASE, Cochrane Library, Web of Science, Google Scholar, Emcare and Academic Search Premier. References were independently screened by two reviewers who also independently assessed the full text of eligible articles and extracted data. Due to the heterogeneity of retrieved studies, narrative summaries were used to present the data. RESULTS: Of the 986 retrieved papers, 23 were eligible for inclusion. In these studies, 184 SSc patients had an anti-reflux surgical procedure and were included in the analysis. Most of the studies were conducted in surgical settings and relevant rheumatological data were largely missing. Refractory GERD symptoms were the most common indication for surgery, with post-operative dysphagia being the most frequent complication. In 14 studies, FP was effective in reducing the GERD symptoms, 1 study had indeterminate findings while in 4 studies, unfavourable results for FP were reported. All the included studies reported a low mortality and morbidity rate related to surgery. CONCLUSIONS: Our data demonstrate that the surgical management of refractory GERD remains a challenge due to the limited evidence, which is largely of poor quality. However, the safety and beneficial effect of FP obtained in the majority of SSc patients, suggests that it may be a beneficial intervention in some patients. The definition of minimal requirements to perform surgical studies on refractory GERD, identifying a specific SSc subset of patients that would most likely benefit from FP, and determining the optimal timing for surgery are warranted.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Matucci-Cerinic P, Akpabio A, Hughes M, et al. The role of surgery in esophageal involvement in systemic sclerosis: A systematic literature review. Semin Arthritis Rheum. 2025. PMID: 40749441. doi:10.1016/j.semarthrit.2025.152791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。